Acta Scientific Ophthalmology (ISSN: 2582-3191)

Research Article Volume 4 Issue 12

Biological Reset and Chronic Glaucoma Healing

Massimo Lombardi*

Center for Regenerative Informational Medicine, Lombardi Eye Clinic, Italy

*Corresponding Author: Massimo Lombardi, Center for Regenerative Informational Medicine, Lombardi Eye Clinic, Italy.

Received: October 18, 2021; Published: November 24, 2021

Abstract

The Author reports in this Article, how, after being affected by Chronic Glaucoma for 40 years, he could finally, through the consistency of the “Evidence Based Medicine”, find the causes of the Sickness and a local and general Cure “Effective and often Decisive” against it, with specific Omotoxicological-Organotherapeutic Chemistries.

Summary: The Author reports with this Article how, after having suffered a Chronic Glaucoma Disease himself (for 40 years), he found an Effective and “often” Resolving Cure with Local and General Therapy against Chronic Glaucoma with Homotoxicological and Organotherapeutic Drugs.

Epidemiology: A rough estimate is that Glaucoma affects about 80,000,000 patients worldwide by calculating the number of patients followed by the various (and not all connected) "Anti-Glaucoma Centers" In my opinion, this value indicated by the O.M.S. only the "Tip of the Iceberg" and does not take into account Asia and Africa where only a few centers are connected with O.M.S. and furthermore in the Westernized World it is likely that there are patients not followed by the Centers but by hospital’ borrowed Eye’ Doctors and/or private Eye Doctors without counting "all those who suffer from it" but have not yet reached a "specific diagnosis" these considerations lead to an “only assumed Estimate” for a total of 600,000,000 patients and for many researchers also this Estimate appears largely approximate.

 

Keywords: Drugs; Healing; Chronic Glaucoma

References

  1. Massimo Lombardi. “Retinal Stem Cells Reprogramming”. Journal of Ophthalmology and Clinical Research (2018).
  2. Massimo Lombardi. “Retinal Stem Cells Reprogramming Using Omotoxicological Pharmaceuticals Blend Therapy” through Retrobulbar Injections”. Journal of Stem Cell Research (2018).
  3. Massimo Lombardi. “Retinal and Body 'Stem Cells Reprogramming”. Acta Scientific Ophthalmology 6 (2021).
  4. Massimo Lombardi. “Keratoconus Etiopathogenesis and True Cure, Modern Concepts”. Journal of Clinical Review and Case Reports (2018).

Citation

Citation: Massimo Lombardi. “Biological Reset and Chronic Glaucoma Healing". Acta Scientific Ophthalmology 4.12 (2021): 76-83.

Copyright

Copyright: © 2021 Massimo Lombardi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
ISI- IF1.042
JCR- IF0.24

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 25, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US